<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-10-01" modified="2020-10-07" version="204">
<accession>P51681</accession>
<accession>O14692</accession>
<accession>O14693</accession>
<accession>O14695</accession>
<accession>O14696</accession>
<accession>O14697</accession>
<accession>O14698</accession>
<accession>O14699</accession>
<accession>O14700</accession>
<accession>O14701</accession>
<accession>O14702</accession>
<accession>O14703</accession>
<accession>O14704</accession>
<accession>O14705</accession>
<accession>O14706</accession>
<accession>O14707</accession>
<accession>O14708</accession>
<accession>O15538</accession>
<accession>Q9UPA4</accession>
<name>CCR5_HUMAN</name>
<protein>
<recommendedName>
<fullName>C-C chemokine receptor type 5</fullName>
<shortName>C-C CKR-5</shortName>
<shortName>CC-CKR-5</shortName>
<shortName>CCR-5</shortName>
<shortName>CCR5</shortName>
</recommendedName>
<alternativeName>
<fullName>CHEMR13</fullName>
</alternativeName>
<alternativeName>
<fullName>HIV-1 fusion coreceptor</fullName>
</alternativeName>
<cdAntigenName>CD195</cdAntigenName>
</protein>
<gene>
<name type="primary">CCR5</name>
<name type="synonym">CMKBR5</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Biochemistry" volume="35" first="3362" last="3367">
<title>Molecular cloning and functional expression of a new human CC-chemokine receptor gene.</title>
<authorList>
<person name="Samson M."/>
<person name="Labbe O."/>
<person name="Mollereau C."/>
<person name="Vassart G."/>
<person name="Parmentier M."/>
</authorList>
<dbReference type="PubMed" id="8639485"/>
<dbReference type="DOI" id="10.1021/bi952950g"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="17161" last="17166">
<title>Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha.</title>
<authorList>
<person name="Raport C.J."/>
<person name="Gosling J."/>
<person name="Schweichart V.L."/>
<person name="Gray P.W."/>
<person name="Charo I.F."/>
</authorList>
<dbReference type="PubMed" id="8663314"/>
<dbReference type="DOI" id="10.1074/jbc.271.29.17161"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCL4 AND CCL5</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Macrophage</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="J. Leukoc. Biol." volume="60" first="147" last="152">
<title>Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1(alpha), MIP-1(beta), and RANTES.</title>
<authorList>
<person name="Combadiere C."/>
<person name="Ahuja S.K."/>
<person name="Tiffany H.L."/>
<person name="Murphy P.M."/>
</authorList>
<dbReference type="PubMed" id="8699119"/>
<dbReference type="DOI" id="10.1002/jlb.60.1.147"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CCL3; CCL4 AND CCL5</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="J. Virol." volume="71" first="8642" last="8656">
<title>Polymorphisms in the CCR5 genes of African green monkeys and mice implicate specific amino acids in infections by simian and human immunodeficiency viruses.</title>
<authorList>
<person name="Kuhmann S.E."/>
<person name="Platt E.J."/>
<person name="Kozak S.L."/>
<person name="Kabat D."/>
</authorList>
<dbReference type="PubMed" id="9343222"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1997" name="AIDS Res. Hum. Retroviruses" volume="13" first="1357" last="1366">
<title>HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism.</title>
<authorList>
<person name="Zhang L."/>
<person name="Carruthers C.D."/>
<person name="He T."/>
<person name="Huang Y."/>
<person name="Cao Y."/>
<person name="Wang G."/>
<person name="Hahn B."/>
<person name="Ho D.D."/>
</authorList>
<dbReference type="PubMed" id="9359654"/>
<dbReference type="DOI" id="10.1089/aid.1997.13.1357"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="30662" last="30671">
<title>The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5'-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons.</title>
<authorList>
<person name="Mummidi S."/>
<person name="Ahuja S.S."/>
<person name="McDaniel B.L."/>
<person name="Ahuja S.K."/>
</authorList>
<dbReference type="PubMed" id="9388201"/>
<dbReference type="DOI" id="10.1074/jbc.272.49.30662"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1999" name="Microbes Infect." volume="1" first="123" last="124">
<title>Novel variant of the CCR5 gene in a Vietnamese population.</title>
<authorList>
<person name="Magierowska M."/>
<person name="Lepage V."/>
<person name="Lien T.X."/>
<person name="Lan N.T."/>
<person name="Guillotel M."/>
<person name="Issafras H."/>
<person name="Reynes J.M."/>
<person name="Fleury H.J."/>
<person name="Chi N.H."/>
<person name="Follezou J.Y."/>
<person name="Debre P."/>
<person name="Theodorou I."/>
<person name="Barre-Sinoussi F."/>
</authorList>
<dbReference type="PubMed" id="10917742"/>
<dbReference type="DOI" id="10.1016/s1286-4579(99)80002-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-178</scope>
</reference>
<reference key="8">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<title>cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org).</title>
<authorList>
<person name="Kopatz S.A."/>
<person name="Aronstam R.S."/>
<person name="Sharma S.V."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1194" last="1198">
<title>The DNA sequence, annotation and analysis of human chromosome 3.</title>
<authorList>
<person name="Muzny D.M."/>
<person name="Scherer S.E."/>
<person name="Kaul R."/>
<person name="Wang J."/>
<person name="Yu J."/>
<person name="Sudbrak R."/>
<person name="Buhay C.J."/>
<person name="Chen R."/>
<person name="Cree A."/>
<person name="Ding Y."/>
<person name="Dugan-Rocha S."/>
<person name="Gill R."/>
<person name="Gunaratne P."/>
<person name="Harris R.A."/>
<person name="Hawes A.C."/>
<person name="Hernandez J."/>
<person name="Hodgson A.V."/>
<person name="Hume J."/>
<person name="Jackson A."/>
<person name="Khan Z.M."/>
<person name="Kovar-Smith C."/>
<person name="Lewis L.R."/>
<person name="Lozado R.J."/>
<person name="Metzker M.L."/>
<person name="Milosavljevic A."/>
<person name="Miner G.R."/>
<person name="Morgan M.B."/>
<person name="Nazareth L.V."/>
<person name="Scott G."/>
<person name="Sodergren E."/>
<person name="Song X.-Z."/>
<person name="Steffen D."/>
<person name="Wei S."/>
<person name="Wheeler D.A."/>
<person name="Wright M.W."/>
<person name="Worley K.C."/>
<person name="Yuan Y."/>
<person name="Zhang Z."/>
<person name="Adams C.Q."/>
<person name="Ansari-Lari M.A."/>
<person name="Ayele M."/>
<person name="Brown M.J."/>
<person name="Chen G."/>
<person name="Chen Z."/>
<person name="Clendenning J."/>
<person name="Clerc-Blankenburg K.P."/>
<person name="Chen R."/>
<person name="Chen Z."/>
<person name="Davis C."/>
<person name="Delgado O."/>
<person name="Dinh H.H."/>
<person name="Dong W."/>
<person name="Draper H."/>
<person name="Ernst S."/>
<person name="Fu G."/>
<person name="Gonzalez-Garay M.L."/>
<person name="Garcia D.K."/>
<person name="Gillett W."/>
<person name="Gu J."/>
<person name="Hao B."/>
<person name="Haugen E."/>
<person name="Havlak P."/>
<person name="He X."/>
<person name="Hennig S."/>
<person name="Hu S."/>
<person name="Huang W."/>
<person name="Jackson L.R."/>
<person name="Jacob L.S."/>
<person name="Kelly S.H."/>
<person name="Kube M."/>
<person name="Levy R."/>
<person name="Li Z."/>
<person name="Liu B."/>
<person name="Liu J."/>
<person name="Liu W."/>
<person name="Lu J."/>
<person name="Maheshwari M."/>
<person name="Nguyen B.-V."/>
<person name="Okwuonu G.O."/>
<person name="Palmeiri A."/>
<person name="Pasternak S."/>
<person name="Perez L.M."/>
<person name="Phelps K.A."/>
<person name="Plopper F.J."/>
<person name="Qiang B."/>
<person name="Raymond C."/>
<person name="Rodriguez R."/>
<person name="Saenphimmachak C."/>
<person name="Santibanez J."/>
<person name="Shen H."/>
<person name="Shen Y."/>
<person name="Subramanian S."/>
<person name="Tabor P.E."/>
<person name="Verduzco D."/>
<person name="Waldron L."/>
<person name="Wang J."/>
<person name="Wang J."/>
<person name="Wang Q."/>
<person name="Williams G.A."/>
<person name="Wong G.K.-S."/>
<person name="Yao Z."/>
<person name="Zhang J."/>
<person name="Zhang X."/>
<person name="Zhao G."/>
<person name="Zhou J."/>
<person name="Zhou Y."/>
<person name="Nelson D."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Naylor S.L."/>
<person name="Yang H."/>
<person name="Olson M."/>
<person name="Weinstock G."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="16641997"/>
<dbReference type="DOI" id="10.1038/nature04728"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="Cell" volume="86" first="367" last="377">
<title>Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.</title>
<authorList>
<person name="Liu R."/>
<person name="Paxton W.A."/>
<person name="Choe S."/>
<person name="Ceradini D."/>
<person name="Martin S.R."/>
<person name="Horuk R."/>
<person name="MacDonald M.E."/>
<person name="Stuhlmann H."/>
<person name="Koup R.A."/>
<person name="Landau N.R."/>
</authorList>
<dbReference type="PubMed" id="8756719"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80110-5"/>
</citation>
<scope>INVOLVEMENT IN RESISTANCE OR SUSCEPTIBILITY TO HIV-1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="Nature" volume="381" first="661" last="666">
<title>Identification of a major co-receptor for primary isolates of HIV-1.</title>
<authorList>
<person name="Deng H."/>
<person name="Liu R."/>
<person name="Ellmeier W."/>
<person name="Choe S."/>
<person name="Unutmaz D."/>
<person name="Burkhart M."/>
<person name="di Marzio P."/>
<person name="Marmon S."/>
<person name="Sutton R.E."/>
<person name="Hill C.M."/>
<person name="Davis C.B."/>
<person name="Peiper S.C."/>
<person name="Schall T.J."/>
<person name="Littman D.R."/>
<person name="Landau N.R."/>
</authorList>
<dbReference type="PubMed" id="8649511"/>
<dbReference type="DOI" id="10.1038/381661a0"/>
</citation>
<scope>FUNCTION AS A HIV-1 CORECEPTOR</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1996" name="Nature" volume="381" first="667" last="673">
<title>HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5.</title>
<authorList>
<person name="Dragic T."/>
<person name="Litwin V."/>
<person name="Allaway G.P."/>
<person name="Martin S.R."/>
<person name="Huang Y."/>
<person name="Nagashima K.A."/>
<person name="Cayanan C."/>
<person name="Maddon P.J."/>
<person name="Koup R.A."/>
<person name="Moore J.P."/>
<person name="Paxton W.A."/>
</authorList>
<dbReference type="PubMed" id="8649512"/>
<dbReference type="DOI" id="10.1038/381667a0"/>
</citation>
<scope>FUNCTION AS A HIV-1 CORECEPTOR</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="Nature" volume="382" first="722" last="725">
<title>Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.</title>
<authorList>
<person name="Samson M."/>
<person name="Libert F."/>
<person name="Doranz B.J."/>
<person name="Rucker J."/>
<person name="Liesnard C."/>
<person name="Farber C.M."/>
<person name="Saragosti S."/>
<person name="Lapoumeroulie C."/>
<person name="Cognaux J."/>
<person name="Forceille C."/>
<person name="Muyldermans G."/>
<person name="Verhofstede C."/>
<person name="Burtonboy G."/>
<person name="Georges M."/>
<person name="Imai T."/>
<person name="Rana S."/>
<person name="Yi Y."/>
<person name="Smyth R.J."/>
<person name="Collman R.G."/>
<person name="Doms R.W."/>
<person name="Vassart G."/>
<person name="Parmentier M."/>
</authorList>
<dbReference type="PubMed" id="8751444"/>
<dbReference type="DOI" id="10.1038/382722a0"/>
</citation>
<scope>INVOLVEMENT IN RESISTANCE OR SUSCEPTIBILITY TO HIV-1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1998" name="Science" volume="280" first="1949" last="1953">
<title>A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.</title>
<authorList>
<person name="Rizzuto C.D."/>
<person name="Wyatt R."/>
<person name="Hernandez-Ramos N."/>
<person name="Sun Y."/>
<person name="Kwong P.D."/>
<person name="Hendrickson W.A."/>
<person name="Sodroski J."/>
</authorList>
<dbReference type="PubMed" id="9632396"/>
<dbReference type="DOI" id="10.1126/science.280.5371.1949"/>
</citation>
<scope>INTERACTION WITH HIV-1 SURFACE PROTEIN GP120</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="Cell" volume="96" first="667" last="676">
<title>Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry.</title>
<authorList>
<person name="Farzan M."/>
<person name="Mirzabekov T."/>
<person name="Kolchinsky P."/>
<person name="Wyatt R."/>
<person name="Cayabyab M."/>
<person name="Gerard N.P."/>
<person name="Gerard C."/>
<person name="Sodroski J."/>
<person name="Choe H."/>
</authorList>
<dbReference type="PubMed" id="10089882"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80577-2"/>
</citation>
<scope>SULFATION AT TYR-3</scope>
<scope>GLYCOSYLATION</scope>
<scope>MUTAGENESIS OF TYR-3; TYR-10; TYR-14 AND TYR-15</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="8875" last="8885">
<title>Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus.</title>
<authorList>
<person name="Oppermann M."/>
<person name="Mack M."/>
<person name="Proudfoot A.E."/>
<person name="Olbrich H."/>
</authorList>
<dbReference type="PubMed" id="10085131"/>
<dbReference type="DOI" id="10.1074/jbc.274.13.8875"/>
</citation>
<scope>PHOSPHORYLATION AT SER-336; SER-337; SER-342 AND SER-349</scope>
<scope>MUTAGENESIS OF SER-336; SER-337; SER-342 AND SER-349</scope>
<scope>INTERACTION WITH GRK2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18902" last="18908">
<title>Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.</title>
<authorList>
<person name="Blanpain C."/>
<person name="Lee B."/>
<person name="Vakili J."/>
<person name="Doranz B.J."/>
<person name="Govaerts C."/>
<person name="Migeotte I."/>
<person name="Sharron M."/>
<person name="Dupriez V."/>
<person name="Vassart G."/>
<person name="Doms R.W."/>
<person name="Parmentier M."/>
</authorList>
<dbReference type="PubMed" id="10383387"/>
<dbReference type="DOI" id="10.1074/jbc.274.27.18902"/>
</citation>
<scope>FUNCTION</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>MUTAGENESIS OF CYS-20; CYS-101; CYS-178 AND CYS-269</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CCL4</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="23795" last="23804">
<title>Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways.</title>
<authorList>
<person name="Blanpain C."/>
<person name="Wittamer V."/>
<person name="Vanderwinden J.-M."/>
<person name="Boom A."/>
<person name="Renneboog B."/>
<person name="Lee B."/>
<person name="Le Poul E."/>
<person name="El Asmar L."/>
<person name="Govaerts C."/>
<person name="Vassart G."/>
<person name="Doms R.W."/>
<person name="Parmentier M."/>
</authorList>
<dbReference type="PubMed" id="11323418"/>
<dbReference type="DOI" id="10.1074/jbc.m100583200"/>
</citation>
<scope>PALMITOYLATION AT CYS-321; CYS-323 AND CYS-324</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF CYS-321; CYS-323 AND CYS-324</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="34408" last="34418">
<title>Characterization of sequence determinants within the carboxyl-terminal domain of chemokine receptor CCR5 that regulate signaling and receptor internalization.</title>
<authorList>
<person name="Kraft K."/>
<person name="Olbrich H."/>
<person name="Majoul I."/>
<person name="Mack M."/>
<person name="Proudfoot A."/>
<person name="Oppermann M."/>
</authorList>
<dbReference type="PubMed" id="11448957"/>
<dbReference type="DOI" id="10.1074/jbc.m102782200"/>
</citation>
<scope>INTERACTION WITH ARRB2</scope>
<scope>MUTAGENESIS OF SER-336; SER-337; SER-342 AND SER-349</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="J. Exp. Med." volume="194" first="1661" last="1673">
<title>Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokines.</title>
<authorList>
<person name="Bannert N."/>
<person name="Craig S."/>
<person name="Farzan M."/>
<person name="Sogah D."/>
<person name="Santo N.V."/>
<person name="Choe H."/>
<person name="Sodroski J."/>
</authorList>
<dbReference type="PubMed" id="11733580"/>
<dbReference type="DOI" id="10.1084/jem.194.11.1661"/>
</citation>
<scope>SULFATION</scope>
<scope>GLYCOSYLATION AT SER-6</scope>
<scope>INTERACTION WITH CCL3; CCL4 AND CCL5</scope>
<scope>MUTAGENESIS OF TYR-3; SER-6; SER-7; TYR-10; TYR-14; TYR-15; THR-16 AND SER-17</scope>
<scope>CHARACTERIZATION OF VARIANT ASP-10</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="FEBS Lett." volume="579" first="1751" last="1758">
<title>JM4 is a four-transmembrane protein binding to the CCR5 receptor.</title>
<authorList>
<person name="Schweneker M."/>
<person name="Bachmann A.S."/>
<person name="Moelling K."/>
</authorList>
<dbReference type="PubMed" id="15757671"/>
<dbReference type="DOI" id="10.1016/j.febslet.2005.02.037"/>
</citation>
<scope>INTERACTION WITH PRAF2</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="37503" last="37515">
<title>G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers.</title>
<authorList>
<person name="Huettenrauch F."/>
<person name="Pollok-Kopp B."/>
<person name="Oppermann M."/>
</authorList>
<dbReference type="PubMed" id="16144840"/>
<dbReference type="DOI" id="10.1074/jbc.m500535200"/>
</citation>
<scope>INTERACTION WITH ARRB1 AND ARRB2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="J. Exp. Med." volume="203" first="35" last="40">
<title>CCR5 deficiency increases risk of symptomatic West Nile virus infection.</title>
<authorList>
<person name="Glass W.G."/>
<person name="McDermott D.H."/>
<person name="Lim J.K."/>
<person name="Lekhong S."/>
<person name="Yu S.F."/>
<person name="Frank W.A."/>
<person name="Pape J."/>
<person name="Cheshier R.C."/>
<person name="Murphy P.M."/>
</authorList>
<dbReference type="PubMed" id="16418398"/>
<dbReference type="DOI" id="10.1084/jem.20051970"/>
</citation>
<scope>INVOLVEMENT IN WEST NILE VIRUS INFECTION SUSCEPTIBILITY</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="Blood" volume="119" first="4908" last="4918">
<title>Human cytomegalovirus-encoded UL33 and UL78 heteromerize with host CCR5 and CXCR4 impairing their HIV coreceptor activity.</title>
<authorList>
<person name="Tadagaki K."/>
<person name="Tudor D."/>
<person name="Gbahou F."/>
<person name="Tschische P."/>
<person name="Waldhoer M."/>
<person name="Bomsel M."/>
<person name="Jockers R."/>
<person name="Kamal M."/>
</authorList>
<dbReference type="PubMed" id="22496149"/>
<dbReference type="DOI" id="10.1182/blood-2011-08-372516"/>
</citation>
<scope>INDUCTION (MICROBIAL INFECTION)</scope>
<scope>INTERACTION WITH HHV-5 PROTEIN UL78</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Traffic" volume="15" first="383" last="400">
<title>CNIH4 interacts with newly synthesized GPCR and controls their export from the endoplasmic reticulum.</title>
<authorList>
<person name="Sauvageau E."/>
<person name="Rochdi M.D."/>
<person name="Oueslati M."/>
<person name="Hamdan F.F."/>
<person name="Percherancier Y."/>
<person name="Simpson J.C."/>
<person name="Pepperkok R."/>
<person name="Bouvier M."/>
</authorList>
<dbReference type="PubMed" id="24405750"/>
<dbReference type="DOI" id="10.1111/tra.12148"/>
</citation>
<scope>INTERACTION WITH CNIH4</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="Biophys. J." volume="83" first="3012" last="3031">
<title>Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.</title>
<authorList>
<person name="Paterlini M.G."/>
</authorList>
<dbReference type="PubMed" id="12496074"/>
<dbReference type="DOI" id="10.1016/s0006-3495(02)75307-1"/>
</citation>
<scope>3D-STRUCTURE MODELING</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="J. Mol. Model." volume="9" first="329" last="336">
<title>Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies.</title>
<authorList>
<person name="Liu S."/>
<person name="Fan S."/>
<person name="Sun Z."/>
</authorList>
<dbReference type="PubMed" id="14517611"/>
<dbReference type="DOI" id="10.1007/s00894-003-0154-9"/>
</citation>
<scope>3D-STRUCTURE MODELING</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="J. Mol. Biol." volume="410" first="778" last="797">
<title>The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.</title>
<authorList>
<person name="Schnur E."/>
<person name="Noah E."/>
<person name="Ayzenshtat I."/>
<person name="Sargsyan H."/>
<person name="Inui T."/>
<person name="Ding F.X."/>
<person name="Arshava B."/>
<person name="Sagi Y."/>
<person name="Kessler N."/>
<person name="Levy R."/>
<person name="Scherf T."/>
<person name="Naider F."/>
<person name="Anglister J."/>
</authorList>
<dbReference type="PubMed" id="21763489"/>
<dbReference type="DOI" id="10.1016/j.jmb.2011.04.023"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-27 IN COMPLEX WITH HIV-1 GP120 AND CD4 MIMIC PEPTIDE</scope>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
<scope>SULFATION AT TYR-10 AND TYR-14</scope>
</reference>
<reference key="30" evidence="2">
<citation type="journal article" date="2013" name="Science" volume="341" first="1387" last="1390">
<title>Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.</title>
<authorList>
<person name="Tan Q."/>
<person name="Zhu Y."/>
<person name="Li J."/>
<person name="Chen Z."/>
<person name="Han G.W."/>
<person name="Kufareva I."/>
<person name="Li T."/>
<person name="Ma L."/>
<person name="Fenalti G."/>
<person name="Li J."/>
<person name="Zhang W."/>
<person name="Xie X."/>
<person name="Yang H."/>
<person name="Jiang H."/>
<person name="Cherezov V."/>
<person name="Liu H."/>
<person name="Stevens R.C."/>
<person name="Zhao Q."/>
<person name="Wu B."/>
</authorList>
<dbReference type="PubMed" id="24030490"/>
<dbReference type="DOI" id="10.1126/science.1241475"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.71 ANGSTROMS) OF 2-223 AND 227-352 IN COMPLEX WITH DRUG</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1997" name="Nat. Genet." volume="16" first="221" last="222">
<title>The extent of genetic variation in the CCR5 gene.</title>
<authorList>
<person name="Ansari-Lari M.A."/>
<person name="Liu X.-M."/>
<person name="Metzker M.L."/>
<person name="Rut A.R."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="9207783"/>
<dbReference type="DOI" id="10.1038/ng0797-221"/>
</citation>
<scope>VARIANTS GLN-55; LEU-215; GLN-223; VAL-335 AND PHE-339</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1997" name="Am. J. Hum. Genet." volume="61" first="1261" last="1267">
<title>Novel alleles of the chemokine-receptor gene CCR5.</title>
<authorList>
<person name="Carrington M."/>
<person name="Kissner T."/>
<person name="Gerrard B."/>
<person name="Ivanov S."/>
<person name="O'Brien S.J."/>
<person name="Dean M."/>
</authorList>
<dbReference type="PubMed" id="9399903"/>
<dbReference type="DOI" id="10.1086/301645"/>
</citation>
<scope>VARIANTS LEU-12; SER-20; SER-29; PHE-42; GLN-55; SER-60; VAL-73; GLN-223; LYS-228 DEL; VAL-301; VAL-335 AND PHE-339</scope>
<scope>ASSOCIATION WITH SUSCEPTIBILITY TO HIV-1</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2001" name="Blood" volume="97" first="3651" last="3654">
<title>A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression.</title>
<authorList>
<person name="Tamasauskas D."/>
<person name="Powell V."/>
<person name="Saksela K."/>
<person name="Yazdanbakhsh K."/>
</authorList>
<dbReference type="PubMed" id="11369664"/>
<dbReference type="DOI" id="10.1182/blood.v97.11.3651"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT SER-60</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2006" name="Retrovirology" volume="3" first="81" last="81">
<title>Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.</title>
<authorList>
<person name="Saez-Cirion A."/>
<person name="Versmisse P."/>
<person name="Truong L.X."/>
<person name="Chakrabarti L.A."/>
<person name="Carpentier W."/>
<person name="Barre-Sinoussi F."/>
<person name="Scott-Algara D."/>
<person name="Pancino G."/>
</authorList>
<dbReference type="PubMed" id="17092330"/>
<dbReference type="DOI" id="10.1186/1742-4690-3-81"/>
</citation>
<scope>INVOLVEMENT IN RESISTANCE TO HIV-1 INFECTION</scope>
<scope>VARIANT ARG-106</scope>
<scope>CHARACTERIZATION OF VARIANTS ARG-106 AND ARG-178</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="N. Engl. J. Med." volume="359" first="2767" last="2777">
<title>Shared and distinct genetic variants in type 1 diabetes and celiac disease.</title>
<authorList>
<person name="Smyth D.J."/>
<person name="Plagnol V."/>
<person name="Walker N.M."/>
<person name="Cooper J.D."/>
<person name="Downes K."/>
<person name="Yang J.H.M."/>
<person name="Howson J.M.M."/>
<person name="Stevens H."/>
<person name="McManus R."/>
<person name="Wijmenga C."/>
<person name="Heap G.A."/>
<person name="Dubois P.C."/>
<person name="Clayton D.G."/>
<person name="Hunt K.A."/>
<person name="van Heel D.A."/>
<person name="Todd J.A."/>
</authorList>
<dbReference type="PubMed" id="19073967"/>
<dbReference type="DOI" id="10.1056/nejmoa0807917"/>
</citation>
<scope>INVOLVEMENT IN IDDM22</scope>
</reference>
<comment type="function">
<text evidence="8 10 22 25 26">Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation.</text>
</comment>
<comment type="function">
<text evidence="8 19 23 24 31">(Microbial infection) Acts as a coreceptor (CD4 being the primary receptor) of human immunodeficiency virus-1/HIV-1.</text>
</comment>
<comment type="subunit">
<text evidence="6 8 12 13 14 15 21 25 26">Interacts with PRAF2 (PubMed:15757671). Efficient ligand binding to CCL3/MIP-1alpha and CCL4/MIP-1beta requires sulfation, O-glycosylation and sialic acid modifications. Glycosylation on Ser-6 is required for efficient binding of CCL4 (PubMed:11733580, PubMed:8663314, PubMed:8699119, PubMed:10383387). Interacts with GRK2 (PubMed:10085131). Interacts with ARRB1 and ARRB2 (PubMed:11448957, PubMed:16144840). Interacts with CNIH4 (PubMed:24405750).</text>
</comment>
<comment type="subunit">
<text evidence="19 31">(Microbial infection) Interacts with HIV-1 surface protein gp120.</text>
</comment>
<comment type="subunit">
<text evidence="20">(Microbial infection) May interact with human cytomegalovirus/HHV-5 protein UL78.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-21403047">
<id>Q16570-2</id>
<label>ACKR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-16640146">
<id>Q92583</id>
<label>CCL17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-6625160">
<id>PRO_0000005165</id>
<label>CCL4</label>
<dbReference type="UniProtKB" id="P13236"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-2848366">
<id>P13501</id>
<label>CCL5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-489374">
<id>P51681</id>
<label>CCR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-353826">
<id>P01730</id>
<label>CD4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-489411">
<id>P61073</id>
<label>CXCR4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-4319440">
<id>P54849</id>
<label>EMP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-489374">
<id>P51681</id>
</interactant>
<interactant intactId="EBI-16027720">
<id>O54081</id>
<label>lukE</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8 10">Cell membrane</location>
<topology evidence="10">Multi-pass membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="22 25">Highly expressed in spleen, thymus, in the myeloid cell line THP-1, in the promyeloblastic cell line KG-1a and on CD4+ and CD8+ T-cells. Medium levels in peripheral blood leukocytes and in small intestine. Low levels in ovary and lung.</text>
</comment>
<comment type="induction">
<text evidence="20">(Microbial infection) May be down-regulated by human cytomegalovirus/HHV-5 protein UL78.</text>
</comment>
<comment type="PTM">
<text evidence="7 13 19">Sulfated on at least 2 of the N-terminal tyrosines. Sulfation contributes to the efficiency of HIV-1 entry and is required for efficient binding of the chemokines, CCL3 and CCL4.</text>
</comment>
<comment type="PTM">
<text evidence="7 13">O-glycosylated, but not N-glycosylated. Ser-6 appears to be the major site. Also sialylated glycans present which contribute to chemokine binding. Thr-16 and Ser-17 may also be glycosylated and, if so, with small moieties such as a T-antigen.</text>
</comment>
<comment type="PTM">
<text evidence="10">Palmitoylation in the C-terminal is important for cell surface expression, and to a lesser extent, for HIV entry.</text>
</comment>
<comment type="PTM">
<text evidence="6">Phosphorylation on serine residues in the C-terminal is stimulated by binding CC chemokines especially by APO-RANTES.</text>
</comment>
<comment type="polymorphism">
<text evidence="17 27 28">Variations in CCR5 are associated with resistance or susceptibility to immunodeficiency virus type 1 (resistance or susceptibility to HIV-1) [MIM:609423]. Variations in CCR5 gene also influence the rate of progression to AIDS after infection.</text>
</comment>
<comment type="polymorphism">
<text evidence="11">Ser-60 variant, a naturally occurring mutation in a conserved residue in the first intracellular domain of CCR5, results in reduced amounts of the protein in the membrane and consequently may be associated with reduced susceptibility to infection by microbes that depend on these molecules as their receptors.</text>
</comment>
<comment type="polymorphism">
<text evidence="16">Variations in CCR5 are associated with susceptibility to West Nile virus (WNV) infection [MIM:610379].</text>
</comment>
<comment type="disease" evidence="18">
<disease id="DI-02780">
<name>Diabetes mellitus, insulin-dependent, 22</name>
<acronym>IDDM22</acronym>
<description>A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.</description>
<dbReference type="MIM" id="612522"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="5">Belongs to the G-protein coupled receptor 1 family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CC_chemokine_receptors"/>
<text>CC chemokine receptors entry</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/CCR5"/>
<text>CCR5 receptor entry</text>
</comment>
<dbReference type="EMBL" id="X91492">
<property type="protein sequence ID" value="CAA62796.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U54994">
<property type="protein sequence ID" value="AAC50598.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U57840">
<property type="protein sequence ID" value="AAB17071.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U83326">
<property type="protein sequence ID" value="AAC51797.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011500">
<property type="protein sequence ID" value="AAB65700.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011501">
<property type="protein sequence ID" value="AAB65701.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011502">
<property type="protein sequence ID" value="AAB65702.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011503">
<property type="protein sequence ID" value="AAB65703.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011505">
<property type="protein sequence ID" value="AAB65705.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011506">
<property type="protein sequence ID" value="AAB65706.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011507">
<property type="protein sequence ID" value="AAB65707.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011508">
<property type="protein sequence ID" value="AAB65708.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011509">
<property type="protein sequence ID" value="AAB65709.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011510">
<property type="protein sequence ID" value="AAB65710.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011511">
<property type="protein sequence ID" value="AAB65711.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011512">
<property type="protein sequence ID" value="AAB65712.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011513">
<property type="protein sequence ID" value="AAB65713.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011514">
<property type="protein sequence ID" value="AAB65714.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011515">
<property type="protein sequence ID" value="AAB65715.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011516">
<property type="protein sequence ID" value="AAB65716.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011517">
<property type="protein sequence ID" value="AAB65717.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011518">
<property type="protein sequence ID" value="AAB65718.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011519">
<property type="protein sequence ID" value="AAB65719.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011520">
<property type="protein sequence ID" value="AAB65720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011521">
<property type="protein sequence ID" value="AAB65721.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011522">
<property type="protein sequence ID" value="AAB65722.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011523">
<property type="protein sequence ID" value="AAB65723.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011524">
<property type="protein sequence ID" value="AAB65724.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011525">
<property type="protein sequence ID" value="AAB65725.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011526">
<property type="protein sequence ID" value="AAB65726.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011527">
<property type="protein sequence ID" value="AAB65727.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011528">
<property type="protein sequence ID" value="AAB65728.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011529">
<property type="protein sequence ID" value="AAB65729.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011530">
<property type="protein sequence ID" value="AAB65730.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011531">
<property type="protein sequence ID" value="AAB65731.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011532">
<property type="protein sequence ID" value="AAB65732.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011533">
<property type="protein sequence ID" value="AAB65733.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011534">
<property type="protein sequence ID" value="AAB65734.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011535">
<property type="protein sequence ID" value="AAB65735.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011536">
<property type="protein sequence ID" value="AAB65736.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF011537">
<property type="protein sequence ID" value="AAB65737.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF031237">
<property type="protein sequence ID" value="AAB94735.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF052539">
<property type="protein sequence ID" value="AAD18131.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY221093">
<property type="protein sequence ID" value="AAO65971.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U95626">
<property type="protein sequence ID" value="AAB57793.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC038398">
<property type="protein sequence ID" value="AAH38398.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS2739.1"/>
<dbReference type="PIR" id="A43113">
<property type="entry name" value="A43113"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000570.1">
<property type="nucleotide sequence ID" value="NM_000579.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001093638.1">
<property type="nucleotide sequence ID" value="NM_001100168.1"/>
</dbReference>
<dbReference type="PDB" id="1ND8">
<property type="method" value="Model"/>
<property type="chains" value="A=1-352"/>
</dbReference>
<dbReference type="PDB" id="1NE0">
<property type="method" value="Model"/>
<property type="chains" value="A=1-352"/>
</dbReference>
<dbReference type="PDB" id="1OPN">
<property type="method" value="Model"/>
<property type="chains" value="A=1-352"/>
</dbReference>
<dbReference type="PDB" id="1OPT">
<property type="method" value="Model"/>
<property type="chains" value="A=1-352"/>
</dbReference>
<dbReference type="PDB" id="1OPW">
<property type="method" value="Model"/>
<property type="chains" value="A=1-352"/>
</dbReference>
<dbReference type="PDB" id="2L87">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-27"/>
</dbReference>
<dbReference type="PDB" id="2MZX">
<property type="method" value="NMR"/>
<property type="chains" value="A=186-195"/>
</dbReference>
<dbReference type="PDB" id="2RLL">
<property type="method" value="NMR"/>
<property type="chains" value="A=7-15"/>
</dbReference>
<dbReference type="PDB" id="2RRS">
<property type="method" value="NMR"/>
<property type="chains" value="A=157-174"/>
</dbReference>
<dbReference type="PDB" id="4MBS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.71"/>
<property type="chains" value="A/B=2-352"/>
</dbReference>
<dbReference type="PDB" id="5UIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=2-352"/>
</dbReference>
<dbReference type="PDB" id="5YD3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="B/D/F/H=11-19"/>
</dbReference>
<dbReference type="PDB" id="5YD4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.35"/>
<property type="chains" value="B/D/F/H=11-19"/>
</dbReference>
<dbReference type="PDB" id="5YD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.96"/>
<property type="chains" value="B/D=11-19"/>
</dbReference>
<dbReference type="PDB" id="5YY4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="B=11-19"/>
</dbReference>
<dbReference type="PDB" id="6FGP">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-27"/>
</dbReference>
<dbReference type="PDB" id="6MEO">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="B=1-313"/>
</dbReference>
<dbReference type="PDB" id="6MET">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="B=1-313"/>
</dbReference>
<dbReference type="PDBsum" id="1ND8"/>
<dbReference type="PDBsum" id="1NE0"/>
<dbReference type="PDBsum" id="1OPN"/>
<dbReference type="PDBsum" id="1OPT"/>
<dbReference type="PDBsum" id="1OPW"/>
<dbReference type="PDBsum" id="2L87"/>
<dbReference type="PDBsum" id="2MZX"/>
<dbReference type="PDBsum" id="2RLL"/>
<dbReference type="PDBsum" id="2RRS"/>
<dbReference type="PDBsum" id="4MBS"/>
<dbReference type="PDBsum" id="5UIW"/>
<dbReference type="PDBsum" id="5YD3"/>
<dbReference type="PDBsum" id="5YD4"/>
<dbReference type="PDBsum" id="5YD5"/>
<dbReference type="PDBsum" id="5YY4"/>
<dbReference type="PDBsum" id="6FGP"/>
<dbReference type="PDBsum" id="6MEO"/>
<dbReference type="PDBsum" id="6MET"/>
<dbReference type="BMRB" id="P51681"/>
<dbReference type="SMR" id="P51681"/>
<dbReference type="BioGRID" id="107639">
<property type="interactions" value="18"/>
</dbReference>
<dbReference type="DIP" id="DIP-5866N"/>
<dbReference type="IntAct" id="P51681">
<property type="interactions" value="17"/>
</dbReference>
<dbReference type="MINT" id="P51681"/>
<dbReference type="STRING" id="9606.ENSP00000292303"/>
<dbReference type="BindingDB" id="P51681"/>
<dbReference type="ChEMBL" id="CHEMBL274"/>
<dbReference type="DrugBank" id="DB05501">
<property type="generic name" value="AMD-070"/>
</dbReference>
<dbReference type="DrugBank" id="DB06497">
<property type="generic name" value="Aplaviroc"/>
</dbReference>
<dbReference type="DrugBank" id="DB05906">
<property type="generic name" value="CCR5 mAb"/>
</dbReference>
<dbReference type="DrugBank" id="DB12698">
<property type="generic name" value="Ibalizumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB12960">
<property type="generic name" value="INCB-9471"/>
</dbReference>
<dbReference type="DrugBank" id="DB05941">
<property type="generic name" value="Leronlimab"/>
</dbReference>
<dbReference type="DrugBank" id="DB04835">
<property type="generic name" value="Maraviroc"/>
</dbReference>
<dbReference type="DrugBank" id="DB06652">
<property type="generic name" value="Vicriviroc"/>
</dbReference>
<dbReference type="DrugCentral" id="P51681"/>
<dbReference type="GuidetoPHARMACOLOGY" id="62"/>
<dbReference type="GlyGen" id="P51681">
<property type="glycosylation" value="4 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="P51681"/>
<dbReference type="PhosphoSitePlus" id="P51681"/>
<dbReference type="SwissPalm" id="P51681"/>
<dbReference type="BioMuta" id="CCR5"/>
<dbReference type="DMDM" id="1705896"/>
<dbReference type="jPOST" id="P51681"/>
<dbReference type="MassIVE" id="P51681"/>
<dbReference type="PaxDb" id="P51681"/>
<dbReference type="PeptideAtlas" id="P51681"/>
<dbReference type="PRIDE" id="P51681"/>
<dbReference type="ProteomicsDB" id="56367"/>
<dbReference type="ABCD" id="P51681">
<property type="antibodies" value="37 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="29674">
<property type="antibodies" value="1694 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000292303">
<property type="protein sequence ID" value="ENSP00000292303"/>
<property type="gene ID" value="ENSG00000160791"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000445772">
<property type="protein sequence ID" value="ENSP00000404881"/>
<property type="gene ID" value="ENSG00000160791"/>
</dbReference>
<dbReference type="GeneID" id="1234"/>
<dbReference type="KEGG" id="hsa:1234"/>
<dbReference type="CTD" id="1234"/>
<dbReference type="DisGeNET" id="1234"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160791.13"/>
<dbReference type="GeneCards" id="CCR5"/>
<dbReference type="HGNC" id="HGNC:1606">
<property type="gene designation" value="CCR5"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160791">
<property type="expression patterns" value="Tissue enhanced (blood)"/>
</dbReference>
<dbReference type="MalaCards" id="CCR5"/>
<dbReference type="MIM" id="601373">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="609423">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="610379">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612522">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P51681"/>
<dbReference type="OpenTargets" id="ENSG00000160791"/>
<dbReference type="Orphanet" id="319269">
<property type="disease" value="Susceptibility/resistance to HIV infection"/>
</dbReference>
<dbReference type="PharmGKB" id="PA26170"/>
<dbReference type="eggNOG" id="KOG3656">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214577"/>
<dbReference type="HOGENOM" id="CLU_009579_8_3_1"/>
<dbReference type="InParanoid" id="P51681"/>
<dbReference type="KO" id="K04180"/>
<dbReference type="OMA" id="HFWKNFQ"/>
<dbReference type="OrthoDB" id="937138at2759"/>
<dbReference type="PhylomeDB" id="P51681"/>
<dbReference type="TreeFam" id="TF330966"/>
<dbReference type="PathwayCommons" id="P51681"/>
<dbReference type="Reactome" id="R-HSA-173107">
<property type="pathway name" value="Binding and entry of HIV virion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-380108">
<property type="pathway name" value="Chemokine receptors bind chemokines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418594">
<property type="pathway name" value="G alpha (i) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783783">
<property type="pathway name" value="Interleukin-10 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="P51681"/>
<dbReference type="SIGNOR" id="P51681"/>
<dbReference type="BioGRID-ORCS" id="1234">
<property type="hits" value="6 hits in 873 CRISPR screens"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P51681"/>
<dbReference type="GeneWiki" id="CCR5"/>
<dbReference type="GenomeRNAi" id="1234"/>
<dbReference type="Pharos" id="P51681">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P51681"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 3"/>
</dbReference>
<dbReference type="RNAct" id="P51681">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160791">
<property type="expression patterns" value="Expressed in visceral pleura and 172 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P51681">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P51681">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009897">
<property type="term" value="C:external side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0003779">
<property type="term" value="F:actin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019957">
<property type="term" value="F:C-C chemokine binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016493">
<property type="term" value="F:C-C chemokine receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071791">
<property type="term" value="F:chemokine (C-C motif) ligand 5 binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019956">
<property type="term" value="F:chemokine binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004950">
<property type="term" value="F:chemokine receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0015026">
<property type="term" value="F:coreceptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004435">
<property type="term" value="F:phosphatidylinositol phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006816">
<property type="term" value="P:calcium ion transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019722">
<property type="term" value="P:calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060326">
<property type="term" value="P:cell chemotaxis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007267">
<property type="term" value="P:cell-cell signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006968">
<property type="term" value="P:cellular defense response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006935">
<property type="term" value="P:chemotaxis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002407">
<property type="term" value="P:dendritic cell chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019064">
<property type="term" value="P:fusion of virus membrane with host plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006955">
<property type="term" value="P:immune response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000110">
<property type="term" value="P:negative regulation of macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007204">
<property type="term" value="P:positive regulation of cytosolic calcium ion concentration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0014808">
<property type="term" value="P:release of sequestered calcium ion into cytosol by sarcoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070723">
<property type="term" value="P:response to cholesterol"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0023052">
<property type="term" value="P:signaling"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR002240">
<property type="entry name" value="Chemokine_CCR5"/>
</dbReference>
<dbReference type="InterPro" id="IPR000355">
<property type="entry name" value="Chemokine_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR000276">
<property type="entry name" value="GPCR_Rhodpsn"/>
</dbReference>
<dbReference type="InterPro" id="IPR017452">
<property type="entry name" value="GPCR_Rhodpsn_7TM"/>
</dbReference>
<dbReference type="Pfam" id="PF00001">
<property type="entry name" value="7tm_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00657">
<property type="entry name" value="CCCHEMOKINER"/>
</dbReference>
<dbReference type="PRINTS" id="PR01110">
<property type="entry name" value="CHEMOKINER5"/>
</dbReference>
<dbReference type="PRINTS" id="PR00237">
<property type="entry name" value="GPCRRHODOPSN"/>
</dbReference>
<dbReference type="PROSITE" id="PS00237">
<property type="entry name" value="G_PROTEIN_RECEP_F1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50262">
<property type="entry name" value="G_PROTEIN_RECEP_F1_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0219">Diabetes mellitus</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0765">Sulfation</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="chain" description="C-C chemokine receptor type 5" id="PRO_0000069257">
<location>
<begin position="1"/>
<end position="352"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="1"/>
<end position="30"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="4">
<location>
<begin position="31"/>
<end position="58"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="59"/>
<end position="68"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="4">
<location>
<begin position="69"/>
<end position="89"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="90"/>
<end position="102"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="4">
<location>
<begin position="103"/>
<end position="124"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="125"/>
<end position="141"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="4">
<location>
<begin position="142"/>
<end position="166"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="167"/>
<end position="198"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="4">
<location>
<begin position="199"/>
<end position="218"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="219"/>
<end position="235"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="4">
<location>
<begin position="236"/>
<end position="260"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="4">
<location>
<begin position="261"/>
<end position="277"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="4">
<location>
<begin position="278"/>
<end position="301"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="4">
<location>
<begin position="302"/>
<end position="352"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="7">
<location>
<position position="3"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="19">
<location>
<position position="10"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="19">
<location>
<position position="14"/>
</location>
</feature>
<feature type="modified residue" description="Sulfotyrosine" evidence="4">
<location>
<position position="15"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by BARK1" evidence="6">
<location>
<position position="336"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by BARK1" evidence="6">
<location>
<position position="337"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by BARK1" evidence="6">
<location>
<position position="342"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by BARK1" evidence="6">
<location>
<position position="349"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="10">
<location>
<position position="321"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="10">
<location>
<position position="323"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="10">
<location>
<position position="324"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="13">
<location>
<position position="6"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="32">
<location>
<position position="7"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) threonine" evidence="4">
<location>
<position position="16"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GalNAc...) serine" evidence="4">
<location>
<position position="17"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3">
<location>
<begin position="20"/>
<end position="269"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 5">
<location>
<begin position="101"/>
<end position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-71A; results in absent sulfation and greatly decreased binding CCL4 and CCL5 when associated with D-3, D-10 and D-15; restored most CCL4 binding when associated with D-3 and D-15." id="VAR_003481" evidence="13">
<original>Y</original>
<variation>D</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_024066" evidence="30">
<original>I</original>
<variation>L</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs145061115." id="VAR_024067" evidence="30">
<original>C</original>
<variation>S</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800939." id="VAR_011839" evidence="30">
<original>A</original>
<variation>S</variation>
<location>
<position position="29"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-72A; dbSNP:rs56340326." id="VAR_003482">
<original>R</original>
<variation>H</variation>
<location>
<position position="31"/>
</location>
</feature>
<feature type="sequence variant" description="In TZCCR5-179." id="VAR_003483">
<original>P</original>
<variation>L</variation>
<location>
<position position="34"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1475319259." id="VAR_024068" evidence="30">
<original>I</original>
<variation>F</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1799863." id="VAR_011840" evidence="29 30">
<original>L</original>
<variation>Q</variation>
<location>
<position position="55"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with susceptibility to HIV-1; reduced surface expression and function of CCR5 protein; dbSNP:rs1800940." id="VAR_011841" evidence="11 30">
<original>R</original>
<variation>S</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In UGCCR5-145B." id="VAR_003484">
<original>K</original>
<variation>R</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In ZWCCR5-7; dbSNP:rs758090461." id="VAR_003485">
<original>Y</original>
<variation>H</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56198941." id="VAR_024069" evidence="30">
<original>A</original>
<variation>V</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In MWCCR5-107; dbSNP:rs149975182." id="VAR_003486">
<original>D</original>
<variation>N</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-467." id="VAR_003487">
<original>G</original>
<variation>E</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; protects against HIV-1 infection; CD4+ T-cells from R-106 carriers are less susceptible to infection by HIV-1 R5; results in reduced CCR5 surface expression; dbSNP:rs183662584." id="VAR_080410" evidence="17">
<original>G</original>
<variation>R</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In ZWCCR5-7." id="VAR_003488">
<original>L</original>
<variation>P</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In UGCCR5-145A." id="VAR_003489">
<original>F</original>
<variation>S</variation>
<location>
<position position="158"/>
</location>
</feature>
<feature type="sequence variant" description="In KECCR5-116." id="VAR_003490">
<original>Y</original>
<variation>C</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-45C." id="VAR_003491">
<original>T</original>
<variation>A</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="sequence variant" description="Rare polymorphism; protects against HIV-1 infection; CD4+ T-cells from R-178 carriers are less susceptible to infection by HIV-1 R5; results in reduced CCR5 surface expression; dbSNP:rs199824195." id="VAR_012481" evidence="9 17">
<original>C</original>
<variation>R</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="sequence variant" description="In UGCCR5-145A." id="VAR_003492">
<original>S</original>
<variation>N</variation>
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In ZWCCR5-7." id="VAR_003493">
<original>M</original>
<variation>V</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In KECCR5-3B." id="VAR_003494">
<original>Y</original>
<variation>C</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1017863136." id="VAR_024070" evidence="29">
<original>S</original>
<variation>L</variation>
<location>
<position position="215"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800452." id="VAR_011842" evidence="29 30">
<original>R</original>
<variation>Q</variation>
<location>
<position position="223"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_024071" evidence="30">
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-71A." id="VAR_003495">
<original>T</original>
<variation>S</variation>
<location>
<position position="239"/>
</location>
</feature>
<feature type="sequence variant" description="In UGCCR5-145A; dbSNP:rs143181119." id="VAR_003496">
<original>L</original>
<variation>P</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In INCCR5-72A; dbSNP:rs534088482." id="VAR_003497">
<original>T</original>
<variation>M</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1800943." id="VAR_011843" evidence="30">
<original>G</original>
<variation>V</variation>
<location>
<position position="301"/>
</location>
</feature>
<feature type="sequence variant" description="In TZCCR5-179." id="VAR_003498">
<original>E</original>
<variation>G</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In THCCR5-5." id="VAR_003499">
<original>K</original>
<variation>E</variation>
<location>
<position position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In MWCCR5-1567." id="VAR_003500">
<original>N</original>
<variation>S</variation>
<location>
<position position="306"/>
</location>
</feature>
<feature type="sequence variant" description="In THCCR5-5." id="VAR_003501">
<original>K</original>
<variation>R</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In THCCR5-2." id="VAR_003502">
<original>E</original>
<variation>G</variation>
<location>
<position position="333"/>
</location>
</feature>
<feature type="sequence variant" description="In MWCCR5-1567, MWCCR5-1568, ZWCCR5-14 and ZWCCR5-112; dbSNP:rs1800944." id="VAR_003503" evidence="29 30">
<original>A</original>
<variation>V</variation>
<location>
<position position="335"/>
</location>
</feature>
<feature type="sequence variant" description="In TZCCR5-181A and MWCCR5-107; dbSNP:rs1800945." id="VAR_003504" evidence="29 30">
<original>Y</original>
<variation>F</variation>
<location>
<position position="339"/>
</location>
</feature>
<feature type="sequence variant" description="In UGCCR5-145C." id="VAR_003505">
<original>E</original>
<variation>G</variation>
<location>
<position position="345"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreased binding of CCL4 and CCL5; when associated with D-10; D-14 and D-15. Restored most CCL4 binding; when associated with D-10 and D-15." evidence="7 13">
<original>Y</original>
<variation>D</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreases binding of CCL4 and CCL5; when associated with F-10; F-14 and F-15." evidence="7 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="3"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in glycosylation status and greatly decreased CCL4 binding. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4; when associated with A-7; A-16; A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4; when associated with A-7 only." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in glycosylation status and binds CCL4 as efficiently as wild type. Loss of molecular mass of about 2 kDa as compared to wild type. Dramatically reduced binding of CCL4; when associated with A-6; A-16; A-17. Similar molecular mass loss. Dramatically reduced binding of CCL4; when associated with A-6 only." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="7"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreases binding of CCL4 and CCL5; when associated with F-3; F-14 and F-15. Small loss of sulfation; when associated with F-14 and F-15." evidence="7 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="10"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreased binding of CCL4 and CCL5; when associated with D-3; D-10 and D-14. No restoration of CCL4 binding; when associated with D-10 and D-15." evidence="7 13">
<original>Y</original>
<variation>D</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreases binding of CCL4 and CCL5; when associated with F-3; F-10; and F-15. Small loss of sulfation; when associated with F-10 and F-15." evidence="7 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreased binding of CCL4 and CCL5; when associated with D-3; D-10 and D-14. Restored most CCL4 binding; when associated with D-3 and D-10." evidence="7 13">
<original>Y</original>
<variation>D</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="No sulfation and greatly decreases binding of CCL4 and CCL5; when associated with F-3; F-10 and F-14. Small loss of sulfation; when associated with F-10 and F-14." evidence="7 13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="15"/>
</location>
</feature>
<feature type="mutagenesis site" description="Similar decrease in molecular mass when treated with O-glycosidase as for wild type; when associated with A-17." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="mutagenesis site" description="Similar decrease in molecular mass when treated with O-glycosidase as for wild type; when associated with A-16." evidence="13">
<original>S</original>
<variation>A</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases to 40% surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases to 40% surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases to 40% surface expression. Disrupts conformational integrity. Disrupts binding of CCL4. Decreases HIV cell infection." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="178"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases to 40% surface expression. No effect on conformational integrity. Disrupts binding of CCL4. Decreases cell HIV infection." evidence="8">
<original>C</original>
<variation>A</variation>
<location>
<position position="269"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small reduction in palmitoylation. Cell surface expression reduced by 50%. Greatly reduced palmitoylation. Cell surface expression greatly reduced; when associated with A-323 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%; when associated with A-323 and A-324." evidence="10">
<original>C</original>
<variation>A</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small reduction in palmitoylation. Cell surface expression reduced by 50%. Greatly reduced palmitoylation. Cell surface expression greatly reduced; when associated with A-321 or A-324. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%; when associated with A-321 and A-324." evidence="10">
<original>C</original>
<variation>A</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small reduction in palmitoylation. Cell surface expression reduced by 50%. Greatly reduced palmitoylation. Cell surface expression greatly reduced; when associated with A-321 or A-323. No palmitoylation. Cell surface expression greatly reduced. HIV entry reduced by 50%; when associated with A-321 and A-323." evidence="10">
<original>C</original>
<variation>A</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="APO-RANTES-stimulated phosphorylation reduced by 15%; APO-RANTES-stimulated phosphorylation reduced by 30-50%; when associated with A-337 or A-342 or A-349; APO-RANTES-stimulated phosphorylation reduced by 80%; when associated with A-337 and A-342 or A-349; No APO-RANTES-stimulated phosphorylation; when associated with A-337; A-342 and A349; abolishes interaction with ARRB2; when associated with S-337; S-342 and S-349." evidence="6 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="mutagenesis site" description="APO-RANTES-stimulated phosphorylation reduced by 18%; APO-RANTES-stimulated phosphorylation reduced by 30-50% on APO-RANTES stimulation; when associated with A-336 or A-342 or A-349; APO-RANTES-stimulated phosphorylation reduced by 80%; when associated with A-336 and A-342 or A-349; No APO-RANTES-stimulated phosphorylation; when associated with A-336; A-342 and A349; abolishes interaction with ARRB2; when associated with S-336; S-342 and S-349." evidence="6 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="APO-RANTES-stimulated phosphorylation reduced by 42%. Phosphorylation reduced by 50% on APO-RANTES stimulation; when associated with A-336 or A-337 or A-349; APO-RANTES-stimulated phosphorylation reduced by 80% when associated with A-336 and A-337 or A-349; No APO-RANTES-stimulated phosphorylation; when associated with A-336; A-337 and A349; abolishes interaction with ARRB2; when associated with S-336; S-337 and S-349." evidence="6 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="342"/>
</location>
</feature>
<feature type="mutagenesis site" description="APO-RANTES-stimulated phosphorylation reduced by 43%; APO-RANTES-stimulated phosphorylation reduced by 30-50%; when associated with A-336 or A-337 or A-342; APO-RANTES-stimulated phosphorylation reduced by 80%; when associated with A-336 and A-337 or A-342; No APO-RANTES-stimulated phosphorylation stimulation; when associated with A-336; A-337 and A347; abolishes interaction with ARRB2; when associated with S-336; S-337 and S-342." evidence="6 12">
<original>S</original>
<variation>A</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="10"/>
<end position="13"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="14"/>
<end position="17"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="23"/>
<end position="57"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="64"/>
<end position="91"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="97"/>
<end position="131"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="136"/>
<end position="139"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="142"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="167"/>
<end position="172"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="175"/>
<end position="180"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="184"/>
<end position="186"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="187"/>
<end position="202"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="204"/>
<end position="221"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="227"/>
<end position="259"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="260"/>
<end position="265"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="269"/>
<end position="288"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="292"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="302"/>
<end position="313"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L87"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MBS"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UIW"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000255"/>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00521"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10085131"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10089882"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10383387"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10917742"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11323418"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11369664"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11448957"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11733580"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15757671"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16144840"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16418398"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17092330"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19073967"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21763489"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22496149"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24405750"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8639485"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8649511"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8649512"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8663314"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8699119"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8751444"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8756719"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9207783"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9399903"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9632396"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10089882"/>
</source>
</evidence>
<sequence length="352" mass="40524" checksum="88ECE1F38E6D45A7" modified="1996-10-01" version="1">MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKRLKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFIILLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSSHFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTIMIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFVGEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

